Evidence map›Paper›PMID 31897241›Full record

ArticleJournal of Cancer2020

Genipin increases oxaliplatin-induced cell death through autophagy in gastric cancer.

Bo Ram Kim, Yoon A Jeong, Dae Young Kim, Jung Lim Kim, Soyeon Jeong, Yoo Jin Na, Hye Kyeong Yun, Seong Hye Park, Min Jee Jo, Hassan Ashktorab and 3 more

Abstract read
In one paragraph

Article in Journal of Cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Frontiers in pharmacology · 2021
    Article
  9. Review
  10. The Role of Autophagy in Gastric Cancer Chemoresistance: Friend or Foe?Frontiers in cell and developmental biology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Bo Ram KimDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Yoon A JeongGraduate School of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Dae Young KimGraduate School of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Jung Lim KimDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Soyeon JeongDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Yoo Jin NaGraduate School of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Hye Kyeong YunGraduate School of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Seong Hye ParkDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Min Jee JoGraduate School of Medicine, Korea University College of Medicine, Seoul, Republic of Korea.
Hassan AshktorabDepartment of Medicine, Howard University, Washington, District of Columbia, 20060, USA.
Duane T SmootDepartment of Medicine, Meharry Medical Center, Nashville, TN, 37208, USA.
Dae-Hee LeeDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
Sang Cheul OhDepartment of Oncology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxaliplatin is used for treatment in combination with many drugs. However, the survival rate is still low due to side effects and drug resistance. Therefore, the combination with natural products was required for increasing efficacy and reducing side effects. Genipin, a natural product derived from the

Indexed as

Autophagy.GenipinOxaliplatinp53

Identifiers

PMID31897241
PMCPMC6930423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.